These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1684016)

  • 41. [All-trans retinoic acid therapy in acute promyelocytic leukemia--current status and prospect].
    Kitamura K; Takeshita A; Ono R; Naoe T
    Rinsho Ketsueki; 1996 Sep; 37(9):760-5. PubMed ID: 8914458
    [No Abstract]   [Full Text] [Related]  

  • 42. Pathogenesis and management of acute promyelocytic leukemia.
    Warrell RP
    Annu Rev Med; 1996; 47():555-65. PubMed ID: 8712802
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differentiation therapy of acute promyelocytic leukemia.
    Chen Z
    Chin Med J (Engl); 1996 Mar; 109(3):179-82. PubMed ID: 8758302
    [No Abstract]   [Full Text] [Related]  

  • 44. Isochromosome for derivative 17q in acute promyelocytic leukemia: evidence for two copies of PML-RARA and favorable response to all-trans-retinoic acid therapy.
    Park JP; Fairweather RB; Mohandas TK
    Genes Chromosomes Cancer; 1997 Feb; 18(2):151-3. PubMed ID: 9115966
    [No Abstract]   [Full Text] [Related]  

  • 45. Differentiation of extramedullary acute promyelocytic leukemia by all-trans-retinoic acid.
    Lederman CA; Weisberger J; Seiter K; Feldman EJ
    Leuk Lymphoma; 1995 Jun; 18(1-2):189-93. PubMed ID: 8580825
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Thrombosis of the cerebral veins and sinuses in acute promyelocytic leukemia after all-trans retinoic acid treatment: a case report and literature review].
    Song LX; Zhou LY; Li X
    Zhonghua Xue Ye Xue Za Zhi; 2012 Nov; 33(11):948-50. PubMed ID: 23363754
    [No Abstract]   [Full Text] [Related]  

  • 47. All-trans-retinoic acid in acute promyelocytic leukemia.
    Tallman MS; Andersen JW; Schiffer CA; Appelbaum FR; Feusner JH; Ogden A; Shepherd L; Willman C; Bloomfield CD; Rowe JM; Wiernik PH
    N Engl J Med; 1997 Oct; 337(15):1021-8. PubMed ID: 9321529
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Superiority of an arsenic trioxide-based regimen over a historic control combining all-trans retinoic acid plus intensive chemotherapy in the treatment of relapsed acute promyelocytic leukemia.
    Thomas X; Pigneux A; Raffoux E; Huguet F; Caillot D; Fenaux P
    Haematologica; 2006 Jul; 91(7):996-7. PubMed ID: 16757416
    [TBL] [Abstract][Full Text] [Related]  

  • 49. All-trans-retinoic acid: what is it good for?
    Warrell RP
    J Clin Oncol; 1992 Nov; 10(11):1659-61. PubMed ID: 1403047
    [No Abstract]   [Full Text] [Related]  

  • 50. All-trans-retinoic acid therapy.
    Wong KF
    Br J Haematol; 2010 May; 149(3):309. PubMed ID: 20064161
    [No Abstract]   [Full Text] [Related]  

  • 51. Leukemia cutis in acute promyelocytic leukemia: report of three cases after treatment with all-trans retinoic acid.
    Giralt S; O'Brien S; Weeks E; Luna M; Kantarjian H
    Leuk Lymphoma; 1994 Aug; 14(5-6):453-6. PubMed ID: 7812204
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A recently recognized entity associated with the treatment of acute promyelocytic leukemia: the retinoic acid syndrome.
    Marinakis T; Papadimitriou CA; Koufos C; Fertakis A
    Haematologica; 1993; 78(3):192-4. PubMed ID: 8375752
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Arsenic treatment for leukemia: new model of human cancer target treatment].
    Zhao WW; Chen SJ
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):439-40. PubMed ID: 15854545
    [No Abstract]   [Full Text] [Related]  

  • 54. Pulmonary embolism in a patient with acute promyelocytic leukemia treated with all-trans retinoic acid.
    Jiménez-Yuste V; Martín MP; Canales M; Ojeda E; Hernández-Navarro F
    Leukemia; 1997 Nov; 11(11):1988-9. PubMed ID: 9369438
    [No Abstract]   [Full Text] [Related]  

  • 55. Successful remission induction by low-dose all-trans retinoic acid alone in a patient with acute promyelocytic leukemia and renal impairment.
    Matsumoto K; Tamaki H; Yamagami T; Sasaki N; Hara S; Soma T
    Leuk Res; 2008 Mar; 32(3):512-4. PubMed ID: 17588659
    [No Abstract]   [Full Text] [Related]  

  • 56. All-trans retinoic acid and arsenic trioxide resistance of acute promyelocytic leukemia with the variant STAT5B-RARA fusion gene.
    Strehl S; König M; Boztug H; Cooper BW; Suzukawa K; Zhang SJ; Chen HY; Attarbaschi A; Dworzak MN
    Leukemia; 2013 Jul; 27(7):1606-10. PubMed ID: 23271512
    [No Abstract]   [Full Text] [Related]  

  • 57. Approaches for an explanation of the differentiating effect of all trans retinoic acid in acute promyelocytic leukemia.
    Degos L
    Leukemia; 1992 Nov; 6 Suppl 4():44-6. PubMed ID: 1434831
    [No Abstract]   [Full Text] [Related]  

  • 58. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.
    Burnett AK; Russell NH; Hills RK; Bowen D; Kell J; Knapper S; Morgan YG; Lok J; Grech A; Jones G; Khwaja A; Friis L; McMullin MF; Hunter A; Clark RE; Grimwade D;
    Lancet Oncol; 2015 Oct; 16(13):1295-305. PubMed ID: 26384238
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combination brings long-term remission in acute promyelocytic leukemia refractory for both all-trans retinoic acid and arsenic trioxide.
    Sasaki M; Sugimoto K; Isobe Y; Oshimi K
    Eur J Haematol; 2008 Aug; 81(2):160. PubMed ID: 18363868
    [No Abstract]   [Full Text] [Related]  

  • 60. Prolonged molecular remission in a newly diagnosed acute promyelocytic leukaemia with a severe cardiomyopathy using low-dose gemtuzumab ozogamicin and all-trans retinoic acid.
    Martini V; Minotti C; Breccia M; De Angelis G; Buffolino S; Mariella M; Lo-Coco F; Avvisati G; Cimino G
    Ann Hematol; 2007 Apr; 86(4):295-7. PubMed ID: 17136541
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.